CELOX™ PPH – Innovation in postpartum hemorrhage stoppage

22 September 2025
Eva Karo

Postpartum hemorrhage (PPH) is still one of the biggest risks to maternal survival postpartum and the leading cause of maternal mortality worldwide. CELOX™ PPH is an innovative haemostatic tamponade dressing, which offers an effective and minimally invasive treatment in situations where every second counts. The product has been specifically developed to help stop postpartum hemorrhage, offering a safe alternative to current treatments and, in many cases, reducing the need for blood transfusions or surgical procedures.

How does it work?

CELOX™ PPH is a haemostatic wound dressing applied locally to the uterus, which forms a bioactive gel upon contact with blood. This gel, which expands into granules, creates a mechanical and biochemical barrier that helps to quickly stop bleeding, supporting the natural clotting process even in patients with coagulopathy. The product can be used for both vaginal and caesarean deliveries.

CELOX™ PPH usage:

  • Continuous bleeding caused by uterine atony
  • Placenta debris in the uterus
  • Bleeding cervical or vaginal ruptures that are difficult to access
  • Cases of postpartum hemorrhage where pharmacological treatment has not given a quick response
  • Patients with coagulation disorders – the product works independently of the patient’s own coagulation process speed

Clinical proof

CELOX™ PPH is already in use in several countries and has received positive feedback from professionals working in maternity care, primarily due to its ease of use and patient safety. Clinical studies have shown a significant increase in hemostasis success, reduced need for blood transfusions, hysterectomies, and other invasive procedures.

CELOX™ products in the Baltics:

Semetron is Celox brand official representative in Estonia, Latvia, and Lithuania. The product is available to medical institutions and is suitable for use in maternity wards, emergency medicine, and critical situations in pre-hospital care.

Request product information or a price quote:
mari-liis.valgevali@semetron.ee (Estonia) inga.grikpede@semetron.lv (Latvia) artur.riutkenen@semetron.lt (Lithuania)


More news

Company news
News
EXIAS e|1 electrolyte analyzer is effortlessly maintenance-free

EXIAS e|1 is a fully automatic IVD analyzer for quantitative... View Article

Company news
News
CELOX™ PPH – Innovation in postpartum hemorrhage stoppage

Postpartum hemorrhage (PPH) is still one of the biggest risks... View Article

News
Projects
The first hybrid mobile CT scanner trailer in Estonia starts operating today

Today, September 16th, the Estonian Cancer Society’s new mobile CT... View Article